Anita Turk, MD, discusses the unmet needs that still exist in the realm of colorectal cancer treatment and management.

Anita Turk, MD, discusses abstracts from ASCO 2025 highlight the evolving role of ctDNA in the management of colorectal ...

Experts are warning that eating any quantity of this food item can increase the risk of developing Type 2 diabetes, ...

Summit Therapeutics nears a $15B AstraZeneca deal for ivonescimab, targeting a $90B market. See more on the potential and ...

HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of oral, small molecule ...

CytoDyn announces encouraging clinical findings among patients with advanced metastatic colorectal cancer previously treated with leronlimab: Vancouver, Washington Friday, July 4, ...

New research from UC Davis Comprehensive Cancer Center has uncovered an evolutionary change that may explain why certain ...

The global snared devices market, valued at $950.2 million in 2021, is projected to reach $1,616.7 million by 2031, expanding at a CAGR of 5.2% from 2022 to 2031. Snared devices are specialized ...

Cases of colon cancer have been on the rise for people under 50 years of age by 3% every year since 2011. According to the ...

Curcumin: The Natural Solution Ignored by Modern Medicine In a world where traditional medicine is often overshadowed by costly and toxic treatments, breakthrough research is shin ...